Our study has identified the dependence of miR-25-3p- and/or miR-15a-5p-regulated chemoresistance in ovarian cancer on miR-18a-3p-K-RAS signaling and its underlying mechanisms (see Figure 6 for model). This evidence concerns the gene KRAS and ovarian cancer.